CANNAFEN
LIVE

Serial Number

79246444

Owner

Senzer Limited

Filing Date

Oct 5, 2018

Add to watchlist:

No watchlists yet
View on USPTO

CANNAFEN Trademark

Serial Number: 79246444 • Registration: 6077024

CANNAFEN is a trademark filed by Senzer Limited on October 5, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Senzer Limited (6 trademarks)

2 Angel Square

Entity Type: 99

Trademark Details

Filing Date

October 5, 2018

Registration Date

June 16, 2020

Published for Opposition

March 31, 2020

Goods & Services

Pharmaceutical preparations for inhalers for the treatment of pain, neuropathy, asthma, chronic obstructive pulmonary disease (copd), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea, stroke, cancer, drug dependence, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, and hepatic, renal, intestinal and cardiovascular disorders; pharmaceutical preparations and substances for use in chemotherapy; pharmaceutical preparations for inhalers for the treatment of pain, neuropathy, asthma, chronic obstructive pulmonary disease (copd), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea, stroke, cancer, drug dependence, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, and hepatic, renal, intestinal and cardiovascular disorders; drug delivery agents in the nature of tablets, liquid medications, inhalers, nasal and oral sprays that facilitate the delivery of a wide range of pharmaceuticals; Transdermal patches and transdermal patches for medical treatment, both for the treatment of pain, neuropathy, asthma, chronic obstructive pulmonary disease (copd), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea, stroke, cancer, drug dependence, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, and hepatic, renal, intestinal and cardiovascular disorders; all of the aforementioned goods containing cannabis that is solely synthetic in nature; sanitary preparations for medical purposes, vaccines, and sanitary sterilising preparations, all not containing cannabis or CBD

Inhalers for medical purposes; medical inhalers; inhalers for medical use; inhalers for therapeutic use; therapeutic inhalers; inhalers for medical purposes, sold empty; all of the aforementioned goods either exclusively for use with cannabis that is solely synthetic in nature, or containing cannabis that is solely synthetic in nature

Filing History

WITHDRAWAL OF ATTORNEY GRANTED
Sep 14, 2023 WOAG
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Sep 14, 2023 WOAR
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 9, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 4, 2020 FICS
FINAL DISPOSITION PROCESSED
Oct 4, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 16, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 16, 2020 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 15, 2020 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 29, 2020 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 29, 2020 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 31, 2020 NPUB
PUBLISHED FOR OPPOSITION
Mar 31, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Mar 27, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 11, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 11, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 11, 2020 NONP
ASSIGNED TO LIE
Feb 27, 2020 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 21, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 21, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 21, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 21, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 21, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 23, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 22, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 22, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 23, 2019 GNRN
NON-FINAL ACTION E-MAILED
Jul 23, 2019 GNRT
NON-FINAL ACTION WRITTEN
Jul 23, 2019 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 26, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 25, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 25, 2019 TROA
REFUSAL PROCESSED BY IB
Jun 21, 2019 RFNT
NEW REPRESENTATIVE AT IB RECEIVED
May 24, 2019 NREP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 20, 2019 GNRN
NON-FINAL ACTION E-MAILED
May 20, 2019 GNRT
NON-FINAL ACTION WRITTEN
May 20, 2019 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 5, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 4, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 4, 2019 TROA
REFUSAL PROCESSED BY IB
Jan 17, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 29, 2018 RFCS
REFUSAL PROCESSED BY MPU
Dec 29, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 18, 2018 RFCR
NON-FINAL ACTION WRITTEN
Dec 17, 2018 CNRT
ASSIGNED TO EXAMINER
Dec 12, 2018 DOCK
ASSIGNED TO EXAMINER
Dec 11, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 4, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 30, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 29, 2018 REPR